Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIAF
DateTimeSourceHeadlineSymbolCompany
12/06/202413:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202414:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202413:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202413:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202413:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
01/04/202414:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202417:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202417:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
08/03/202402:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
06/03/202415:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202414:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202422:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202413:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
21/02/202413:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
06/02/202413:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
31/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
30/01/202413:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
23/01/202413:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
08/01/202413:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
08/12/202321:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
05/12/202313:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

Your Recent History

Delayed Upgrade Clock